表紙
市場調查報告書

醫療用塑膠市場的COVID-19的影響:各種類(工程塑膠、標準塑膠)、用途(醫療用拋棄式產品、義肢、醫療設備、藥物輸送)、地區:到2021年的全球市場預測

COVID-19 Impact On Medical Plastics Market by Type (Engineering Plastics and Standard Plastics), Application (Medical Disposables, Prosthetics, Medical Instruments & Tools and Drug Delivery) and Region - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 933789
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
醫療用塑膠市場的COVID-19的影響:各種類(工程塑膠、標準塑膠)、用途(醫療用拋棄式產品、義肢、醫療設備、藥物輸送)、地區:到2021年的全球市場預測 COVID-19 Impact On Medical Plastics Market by Type (Engineering Plastics and Standard Plastics), Application (Medical Disposables, Prosthetics, Medical Instruments & Tools and Drug Delivery) and Region - Global Forecast to 2021
出版日期: 2020年04月24日內容資訊: 英文 58 Pages
簡介

COVID-19大流行的期間中,全球醫療用塑膠市場,從2020年的251億美元規模到2021年的294億美元規模,年複合成長率預計成為17.2%。醫療用塑膠產業主要的推動要素,包含對人工呼吸器,熱感掃描機,呼吸系統等重症加護系統生產的OEM和醫療設備廠商的需求高漲。

本報告提供全球醫療用塑膠市場的COVID-19的影響相關調查分析,市場概要,各種類、用途、地區的市場考察,以及主要企業的策略等總括性彙整。

第1章 簡介

第2章 COVID-19對醫療用塑膠產業的影響

  • 簡介
  • 醫療用塑膠產業的價值鏈
  • 宏觀經濟學的指標

第3章 客戶分析

第4章 COVID-19對醫療用塑膠的各市場區隔的影響

  • 在醫療產業前幾名的用途
    • 醫療用拋棄式產品
    • 醫療設備
    • 藥物輸送
  • 在醫療產業的倒數幾名的用途
    • 義肢
    • 牙科用設備
  • 在醫療產業前幾名的聚合物種類
    • 標準塑膠
    • 工程塑膠
    • 其他
  • 獲得最大的恩惠的企業:各頂端企業

第5章 COVID-19對醫療用塑膠產業的影響:各地區

第6章 COVID-19大流行期間中的塑膠企業的策略

  • SABIC
  • BASF
  • CELANESE CORPORATION
  • SOLVAY
  • ARKEMA
  • COVESTRO
  • ENSINGER
  • LUBRIZOL
  • EVONIK
  • TRINSEO
  • 其他的發展

第7章 附錄

目錄
Product Code: CH 7612

"The global medical plastics market is projected to register a CAGR of 17.2%, in terms of value, between 2020 and 2021. This is approximately 10% higher than earlier pre-COVID growth projections."

The global medical plastics market size during this COVID-19 pandemic is projected to grow from USD 25.1 billion in 2020 to USD 29.4 billion by 2021, at a CAGR of 17.2%. The major drivers for the medical plastics industry include the growing d4mand from OEMs and medical device/equipment manufacturers for the production of critical care systems such as ventilators, thermal scanners, and respirators.

The medical disposables segment is estimated to be the largest application of medical plastics during the forecast period.

The medical disposables segment accounts for the largest share in the medical plastics market. The use of medical plastics is increasing due to their usefulness. Medical disposables can be defined as single-use products that are used in surgical as well as procedural applications. The use of these medical products in procedural applications and general checkup is increasing. In addition, the use of these disposables as instructed by various agencies, such as USFDA and Europe EMA, are propelling the demand for medical plastics globally. Increased demand for disposables such as gloves, masks, gowns, and other PPEs will drive the market during this pandemic.

The standard plastics segment is expected to be the fastest-growing type of medical plastics during the forecast period.

Standard plastics are sourced from crude oil and are non-renewables. These plastics generally include PVC, PE, PP, PS, PMMA, and EVA. The major applications of these plastics include the manufacturing of masks, gloves, drapes, gowns, trays, catheters, syringes, orthopedic devices, surgical tools, and lab wares. Increased requirements of personal protective equipment (PPE) such as face shields, masks, gloves, drapes, single-use syringes, and others will boost consumption of standard plastics such as PP, PE, and PVC drive demand.

Europe is expected to be the fastest-growing medical plastics market during the crisis period.

The medical plastics market in Europe has witnessed a considerable demand driven by the growing requirement for ventilators, respirators, thermal scanners, and other patient care systems. Europe consists of some profoundly affected countries such as Italy, Spain, Germany, and France, among others, which have a large demand for patient care systems. In addition, growth in the requirement of PPEs will also drive demand for medical plastics in the region.

The market sizes estimated in this study were validated through primary interviews conducted with various industry experts globally. These primary sources are divided into three categories:

  • By Company Type: Tier I - 25%, Tier II - 50%, and Tier III - 25%
  • By Designation: C Level - 20%, Director Level - 30%, and Others - 50%
  • By Region: North America - 20%, Europe - 30%, APAC - 25%, South America - 25%, Middle East & Africa - 10%

The report profiles several leading players of the medical plastics market that include SABIC (Saudi Arabia), BASF (Germany), Celanese (US), Evonik (Germany), Solvay (Belgium) and Covestro (Germany). The report also includes detailed information about various growth strategies adopted by these key players to strengthen their position in the market during this crisis period.

RESEARCH COVERAGE

The objective of this study is to define, describe, and forecast the impact of COVID-19 on the medical plastics market based on various segmentations and strategically analyze these market segments with respect to individual growth trends, growth prospects, and contribution to the overall growth. In this report, the medical plastics market has been segmented based on application, type, and region.

KEY BENEFITS OF BUYING THE REPORT

The report is expected to help companies in the medical plastics market in the following ways:

  • 1. This report comprehensively segments the impact of COVID-19 on the medical plastics market. It provides the closest approximations for the sizes of different segments and sub-segments of the market across different verticals and regions.
  • 2. This report is expected to help stakeholders in obtaining an improved understanding of their competitors and gain insights about their businesses during this period. The competitive landscape section includes detailed information about strategies, such as donations, increased production, partnerships, which were undertaken by various key players to enhance their position in the medical plastics market during this crisis period.

TABLE OF CONTENTS

1 INTRODUCTION 11

  • 1.1 OBJECTIVES OF THE STUDY 11
  • 1.2 MARKET DEFINITION 11
    • 1.2.1 MEDICAL PLASTICS 11
    • 1.2.2 COVID-19 11
  • 1.3 CONFIRMED CASES AND DEATHS, BY GEOGRAPHY 12
  • 1.4 MARKET SCOPE 12
  • 1.5 CURRENCY 13
  • 1.6 UNIT CONSIDERED 14
  • 1.7 STAKEHOLDERS 14
  • 1.8 LIMITATIONS 14

2 COVID-19 IMPACT ON MEDICAL PLASTICS ECOSYSTEM 15

  • 2.1 INTRODUCTION 15
  • 2.2 VALUE CHAIN OF MEDICAL PLASTICS INDUSTRY 15
    • 2.2.1 RAW MATERIAL SUPPLIERS 16
    • 2.2.2 MANUFACTURERS 16
    • 2.2.3 DISTRIBUTORS/CONVERTORS 16
    • 2.2.4 OEM/MEDICAL DEVICE MANUFACTURERS 16
  • 2.3 MACROECONOMIC INDICATORS 17
    • 2.3.1 DRIVERS 17
      • 2.3.1.1 Growing awareness & concern about health & personal hygiene 17
      • 2.3.1.2 Growing demand for medical plastics from various end users in healthcare industry 18
    • 2.3.2 CHALLENGES 18
      • 2.3.2.1 Maintaining supply chain and logistics 18
      • 2.3.2.2 Restricting counterfeit products 18

3 CUSTOMER ANALYSIS 19

  • 3.1 INTRODUCTION 19
    • 3.1.1 SHIFT IN HEALTHCARE INDUSTRY 19
      • 3.1.1.1 Disruption in the industry 19
      • 3.1.1.2 Impact on customers' output & strategies to improve production 19
      • 3.1.1.3 Impact on customers' revenues 20
      • 3.1.1.4 Customer's most crucial regions 21
      • 3.1.1.5 Short-term strategies to manage cost structure and supply chains 21
    • 3.1.2 NEW MARKET OPPORTUNITIES/GROWTH OPPORTUNITIES 21
      • 3.1.2.1 Measures taken by customers 21
      • 3.1.2.2 Customers perspective on the growth outlook 21

4 IMPACT OF COVID-19 ON MEDICAL PLASTICS SEGMENTS 22

  • 4.1 TOP APPLICATIONS IN HEALTHCARE INDUSTRY 22
    • 4.1.1 MEDICAL DISPOSABLES 22
    • 4.1.2 MEDICAL INSTRUMENTS & TOOLS 23
    • 4.1.3 DRUG DELIVERY 23
  • 4.2 BOTTOM RANKING APPLICATIONS IN HEALTHCARE INDUSTRY 23
    • 4.2.1 PROSTHETICS 23
    • 4.2.2 DENTAL TOOLS 23
  • 4.3 TOP POLYMER TYPES IN HEALTHCARE INDUSTRY 24
    • 4.3.1 STANDARD PLASTICS 25
      • 4.3.1.1 PVC 25
      • 4.3.1.2 PP 25
      • 4.3.1.3 PE 25
    • 4.3.2 ENGINEERING PLASTICS 26
      • 4.3.2.1 PC 26
      • 4.3.2.2 PA 26
      • 4.3.2.3 PET 26
    • 4.3.3 OTHERS 26
      • 4.3.3.1 PEEK 26
      • 4.3.3.2 TPE & TPU 27
      • 4.3.3.3 Others 27
  • 4.4 BIGGEST GAINERS, BY TOP COMPANIES 27

5 IMPACT OF COVID-19 IN MEDICAL PLASTICS MARKET, BY REGION 28

  • 5.1 INTRODUCTION 28
  • 5.2 APAC 28
    • 5.2.1 CHINA 28
    • 5.2.2 INDIA 30
    • 5.2.3 JAPAN 31
  • 5.3 EUROPE 32
    • 5.3.1 ITALY 32
    • 5.3.2 GERMANY 33
    • 5.3.3 SPAIN 34
    • 5.3.4 UK 35
  • 5.4 NORTH AMERICA 36
    • 5.4.1 US 36
  • 5.5 REST OF WORLD 37

6 STRATEGIES OF MEDICAL PLASTICS COMPANIES DURING COVID-19 PANDEMIC 39

  • 6.1 SABIC 39
    • 6.1.1 IMPACT ON COMPANY PORTFOLIO 39
      • 6.1.1.1 Product/Material 39
      • 6.1.1.2 Application 39
      • 6.1.1.3 COVID-19 related developments/Strategy 39
  • 6.2 BASF 40
    • 6.2.1 IMPACT ON COMPANY PORTFOLIO 40
      • 6.2.1.1 Product/Material 40
      • 6.2.1.2 Application 40
      • 6.2.1.3 COVID-19 related developments/strategy 40
  • 6.3 CELANESE CORPORATION 41
    • 6.3.1 IMPACT ON COMPANY PORTFOLIO 41
      • 6.3.1.1 Product/Material 41
      • 6.3.1.2 Application 41
      • 6.3.1.3 COVID-19 related developments/strategy 41
  • 6.4 SOLVAY 42
    • 6.4.1 IMPACT ON COMPANY PORTFOLIO 42
      • 6.4.1.1 Product/Material 42
      • 6.4.1.2 Application 42
      • 6.4.1.3 COVID-19 related developments/strategy 42
  • 6.5 ARKEMA 43
    • 6.5.1 IMPACT ON COMPANY PORTFOLIO 43
      • 6.5.1.1 Product/Material 43
      • 6.5.1.2 Application 43
      • 6.5.1.3 COVID-19 related developments/strategy 43
  • 6.6 COVESTRO 44
    • 6.6.1 IMPACT ON COMPANY PORTFOLIO 44
      • 6.6.1.1 Product/Material 44
      • 6.6.1.2 Application 44
      • 6.6.1.3 COVID-19 related developments/strategy 44
  • 6.7 ENSINGER 45
    • 6.7.1 IMPACT ON COMPANY PORTFOLIO 45
      • 6.7.1.1 Product/Material 45
      • 6.7.1.2 Application 45
      • 6.7.1.3 COVID-19 related developments/strategy 45
  • 6.8 LUBRIZOL 46
    • 6.8.1 IMPACT ON COMPANY PORTFOLIO 46
      • 6.8.1.1 Product/Material 46
      • 6.8.1.2 Application 46
      • 6.8.1.3 COVID-19 related developments/strategy 46
  • 6.9 EVONIK 47
    • 6.9.1 IMPACT ON COMPANY PORTFOLIO 47
      • 6.9.1.1 Product/Material 47
      • 6.9.1.2 Application 47
      • 6.9.1.3 COVID-19 related developments/strategy 47
  • 6.10 TRINSEO 48
    • 6.10.1 IMPACT ON COMPANY PORTFOLIO 48
      • 6.10.1.1 Product/Material 48
      • 6.10.1.2 Application 48
      • 6.10.1.3 COVID-19 related developments/strategy 48
  • 6.11 OTHER RELATED DEVELOPMENTS 49

7 APPENDIX 51

  • 7.1 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 55
  • 7.2 AUTHOR DETAILS 57

LIST OF TABLES

  • TABLE 1 MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 22
  • TABLE 2 MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 22
  • TABLE 3 MAPPING OF POLYMERS WITH PROCESSING TECHNOLOGIES 24
  • TABLE 4 MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2021 (KILOTON) 24
  • TABLE 5 MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2021 (USD MILLION) 25
  • TABLE 6 MEDICAL PLASTICS MARKET SIZE, BY REGION, 2018-2021 (KILOTON) 28
  • TABLE 7 MEDICAL PLASTICS MARKET SIZE, BY REGION, 2018-2021 (USD MILLION) 28
  • TABLE 8 CHINA: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 29
  • TABLE 9 CHINA: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 29
  • TABLE 10 INDIA: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 30
  • TABLE 11 INDIA: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 31
  • TABLE 12 JAPAN: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 31
  • TABLE 13 JAPAN: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 32
  • TABLE 14 ITALY: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 32
  • TABLE 15 ITALY: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 33
  • TABLE 16 GERMANY: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 33
  • TABLE 17 GERMANY: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 34
  • TABLE 18 SPAIN: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 34
  • TABLE 19 SPAIN: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 35
  • TABLE 20 UK: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 35
  • TABLE 21 UK: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 36
  • TABLE 22 US: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 37
  • TABLE 23 US: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 37
  • TABLE 24 ROW: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (KILOTON) 38
  • TABLE 25 ROW: MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2021 (USD MILLION) 38

LIST OF FIGURES

  • FIGURE 1 COVID-19'S PACE OF GLOBAL PROPAGATION IS UNPRECEDENTED 12
  • FIGURE 2 MEDICAL PLASTICS MARKET SEGMENTATION 12
  • FIGURE 3 REGIONS COVERED 13
  • FIGURE 4 YEARS CONSIDERED FOR THE STUDY 13
  • FIGURE 5 OVERVIEW OF MEDICAL PLASTICS VALUE CHAIN 16
  • FIGURE 6 COVID-19 IMPACT ON MEDICAL PLASTIC ECOSYSTEM 17